Evidence map›Paper›PMID 42017672›Full record

ArticleThe Journal of the Association of Nurses in AIDS Care : JANAC2026

Cannabis Use and the Risk of Incident Venous Thromboembolism Among People With HIV: A Longitudinal Cohort Study in the United States.

Lara Haidar, Robin M Nance, Stephanie A Ruderman, Andrew Hahn, Jeanne Keruly, Kristina Crothers, Mari M Kitahata, Sonia Napravnik, Richard D Moore, Geetanjali Chander and 15 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of the Association of Nurses in AIDS Care : JANAC, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Lara HaidarLara Haidar, PharmD, is a PhD Candidate, College of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada.
Robin M NanceLara Haidar, PharmD, is a PhD Candidate, College of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada.
Stephanie A RudermanLara Haidar, PharmD, is a PhD Candidate, College of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada.ORCID 0000-0002-0058-5729
Andrew HahnLara Haidar, PharmD, is a PhD Candidate, College of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada.ORCID 0000-0002-9552-1700
Jeanne KerulyLara Haidar, PharmD, is a PhD Candidate, College of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada.ORCID 0000-0002-8489-435
Kristina CrothersLara Haidar, PharmD, is a PhD Candidate, College of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada.ORCID 0000-0001-9702-0371
Mari M KitahataLara Haidar, PharmD, is a PhD Candidate, College of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada.ORCID 0000-0002-5410-7175
Sonia NapravnikLara Haidar, PharmD, is a PhD Candidate, College of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada.
Richard D MooreLara Haidar, PharmD, is a PhD Candidate, College of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada.
Geetanjali ChanderLara Haidar, PharmD, is a PhD Candidate, College of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada.ORCID 0000-0002-2216-6330
Edward CachayLara Haidar, PharmD, is a PhD Candidate, College of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada.ORCID 0000-0002-2452-7558
Laura BamfordLara Haidar, PharmD, is a PhD Candidate, College of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada.
Jimmy MaLara Haidar, PharmD, is a PhD Candidate, College of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada.
Rob FredericksenLara Haidar, PharmD, is a PhD Candidate, College of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada.
Michael S SaagLara Haidar, PharmD, is a PhD Candidate, College of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada.ORCID 0000-0002-8866-1043
Greer BurkholderLara Haidar, PharmD, is a PhD Candidate, College of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada.
Sonya HeathLara Haidar, PharmD, is a PhD Candidate, College of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada.ORCID 0000-0002-3826-0954
Bridget M WhitneyLara Haidar, PharmD, is a PhD Candidate, College of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada.ORCID 0000-0002-3738-5704
Lydia N DrumrightLara Haidar, PharmD, is a PhD Candidate, College of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada.ORCID 0000-0002-3361-8080
Engi F AttiaLara Haidar, PharmD, is a PhD Candidate, College of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada.ORCID 0000-0002-5044-9602
L Sarah MixsonLara Haidar, PharmD, is a PhD Candidate, College of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada.
Peter HuntLara Haidar, PharmD, is a PhD Candidate, College of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada.ORCID 0000-0002-4571-4870
Joseph A C DelaneyLara Haidar, PharmD, is a PhD Candidate, College of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada.ORCID 0000-0003-1771-1776
Heidi M CraneLara Haidar, PharmD, is a PhD Candidate, College of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada.ORCID 0000-0002-3308-7005
Sherif EltonsyLara Haidar, PharmD, is a PhD Candidate, College of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada.ORCID 0000-0002-0520-5406

Funding

Unsolicited R24 for the CFAR-Network of Integrated Clinical Sciences, CNICSR24AI067039 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Michael S. Saag · 2006 to 2026
$99.4M
Substance use patterns and contexts: impact on epigenetic age and prevention strategies in an HIV clinical care cohortR01DA047045 · NIDA · UNIVERSITY OF WASHINGTON · PI Heidi M. Crane, Joseph Austin Delaney · 2018 to 2026
$5.1M
Links between Cardiovascular disease, Lung disease, and Obstructive sleep apnea in HIV: Understanding complex patientsR01HL126538 · NHLBI · UNIVERSITY OF WASHINGTON · PI CRANE, HEIDI M., CROTHERS, KRISTINA ANNE · 2015 to 2025
$5.1M
Understanding Health Inequities at the Intersection of the HIV and substance use epidemics across racial/ethnic and other underserved populationsR01DA058938 · NIDA · UNIVERSITY OF WASHINGTON · PI Heidi M. Crane, Rob Fredericksen · 2023 to 2026
$2.8M
NHLBI NIH HHS R01 HL126538NIAID NIH HHS R24 AI067039NIDA NIH HHS R01 DA047045NIDA NIH HHS R01 DA058938
6 · The paper itself

Abstract

abstractPeople with HIV (PWH) are at an increased risk of venous thromboembolism (VTE), and cannabis use is common in this population. However, evidence of cannabis impact on VTE risk has been conflicting and not well evaluated in PWH. Using data from five Centers for AIDS Research Network of Integrated Clinical Systems sites (2009-2020), we assessed the association between cannabis use and VTE risk. Among 13,646 PWH, 30% reported current cannabis use. In adjusted Cox models, neither former (adjusted hazard ratio [aHR] 0.78, 95% confidence interval (CI) 0.57-1.07) nor current (aHR 0.74, 95% CI 0.51-1.06) cannabis use showed a significant increase in VTE incidence compared with never use. Additionally, no dose-dependent relationship was observed between cannabis use frequency and VTE. Among PWH, cannabis use does not appear to be associated with an elevated risk of VTE. Further research is needed to elucidate the relationship between cannabis and VTE risk in this population.

Indexed as

cannabiscohort studyHIVvenous thromboembolism

Identifiers

PMID42017672
PMCPMC13221268

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.